NCATS to Announce Awards for Discovering New Therapeutic Uses for Existing Molecules Program
6/14/2013 2:26:19 PM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
What: The National Center for Advancing Translational Sciences (NCATS) is holding a press telebriefing to announce awards for the Discovering New Therapeutic Uses for Existing Molecules (New Therapeutic Uses) pilot program.
Who: Christopher P. Austin, M.D., NCATS Director
When: Tuesday, June 18, 2013, at 11:30 a.m. ET.
How: 1- 888-847-9709, passcode: NCATS
Please call in 5 to 10 minutes prior to the start of the telebriefing. Media will be asked for name and outlet.
Program Information: For background information about the New Therapeutic Uses program, please visit http://ncats.nih.gov/therapeutics.html.
The National Center for Advancing Translational Sciences (NCATS) is a distinctly different entity in the research ecosystem. Rather than targeting a particular disease and fundamental science, NCATS focuses on what is common across diseases and the translational process. The Center emphasizes innovation and deliverables, relying on the power of data and new technologies to develop, demonstrate and disseminate improvements in translational science. For more information, visit www.ncats.nih.gov.
About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit http://www.nih.gov.
Help employers find you! Check out all the jobs and post your resume.
comments powered by